PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ELMD vs. BSX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ELMD and BSX is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.1

Performance

ELMD vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Electromed, Inc. (ELMD) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

500.00%1,000.00%1,500.00%2,000.00%NovemberDecember2025FebruaryMarchApril
472.61%
1,635.77%
ELMD
BSX

Key characteristics

Sharpe Ratio

ELMD:

1.16

BSX:

1.76

Sortino Ratio

ELMD:

1.79

BSX:

2.27

Omega Ratio

ELMD:

1.22

BSX:

1.36

Calmar Ratio

ELMD:

1.55

BSX:

2.55

Martin Ratio

ELMD:

3.53

BSX:

11.06

Ulcer Index

ELMD:

16.52%

BSX:

3.58%

Daily Std Dev

ELMD:

50.39%

BSX:

22.48%

Max Drawdown

ELMD:

-78.65%

BSX:

-89.15%

Current Drawdown

ELMD:

-35.68%

BSX:

-10.42%

Fundamentals

Market Cap

ELMD:

$195.01M

BSX:

$140.88B

EPS

ELMD:

$0.75

BSX:

$1.25

PE Ratio

ELMD:

30.39

BSX:

76.20

PEG Ratio

ELMD:

0.00

BSX:

1.87

PS Ratio

ELMD:

3.27

BSX:

8.41

PB Ratio

ELMD:

4.47

BSX:

6.47

Total Revenue (TTM)

ELMD:

$45.76M

BSX:

$12.89B

Gross Profit (TTM)

ELMD:

$35.42M

BSX:

$8.58B

EBITDA (TTM)

ELMD:

$7.03M

BSX:

$2.88B

Returns By Period

In the year-to-date period, ELMD achieves a -22.88% return, which is significantly lower than BSX's 6.49% return. Over the past 10 years, ELMD has outperformed BSX with an annualized return of 25.49%, while BSX has yielded a comparatively lower 17.96% annualized return.


ELMD

YTD

-22.88%

1M

-7.17%

6M

-1.26%

1Y

63.49%

5Y*

10.15%

10Y*

25.49%

BSX

YTD

6.49%

1M

-5.57%

6M

8.00%

1Y

41.09%

5Y*

20.01%

10Y*

17.96%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ELMD vs. BSX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELMD
The Risk-Adjusted Performance Rank of ELMD is 8585
Overall Rank
The Sharpe Ratio Rank of ELMD is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of ELMD is 8484
Sortino Ratio Rank
The Omega Ratio Rank of ELMD is 8181
Omega Ratio Rank
The Calmar Ratio Rank of ELMD is 9191
Calmar Ratio Rank
The Martin Ratio Rank of ELMD is 8282
Martin Ratio Rank

BSX
The Risk-Adjusted Performance Rank of BSX is 9494
Overall Rank
The Sharpe Ratio Rank of BSX is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of BSX is 9090
Sortino Ratio Rank
The Omega Ratio Rank of BSX is 9292
Omega Ratio Rank
The Calmar Ratio Rank of BSX is 9696
Calmar Ratio Rank
The Martin Ratio Rank of BSX is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ELMD vs. BSX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Electromed, Inc. (ELMD) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ELMD, currently valued at 1.16, compared to the broader market-2.00-1.000.001.002.003.00
ELMD: 1.16
BSX: 1.76
The chart of Sortino ratio for ELMD, currently valued at 1.79, compared to the broader market-6.00-4.00-2.000.002.004.00
ELMD: 1.79
BSX: 2.27
The chart of Omega ratio for ELMD, currently valued at 1.22, compared to the broader market0.501.001.502.00
ELMD: 1.22
BSX: 1.36
The chart of Calmar ratio for ELMD, currently valued at 1.55, compared to the broader market0.001.002.003.004.00
ELMD: 1.55
BSX: 2.55
The chart of Martin ratio for ELMD, currently valued at 3.53, compared to the broader market-5.000.005.0010.0015.0020.00
ELMD: 3.53
BSX: 11.06

The current ELMD Sharpe Ratio is 1.16, which is lower than the BSX Sharpe Ratio of 1.76. The chart below compares the historical Sharpe Ratios of ELMD and BSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00NovemberDecember2025FebruaryMarchApril
1.16
1.76
ELMD
BSX

Dividends

ELMD vs. BSX - Dividend Comparison

Neither ELMD nor BSX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ELMD vs. BSX - Drawdown Comparison

The maximum ELMD drawdown since its inception was -78.65%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for ELMD and BSX. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-35.68%
-10.42%
ELMD
BSX

Volatility

ELMD vs. BSX - Volatility Comparison

The current volatility for Electromed, Inc. (ELMD) is 10.78%, while Boston Scientific Corporation (BSX) has a volatility of 13.44%. This indicates that ELMD experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
10.78%
13.44%
ELMD
BSX

Financials

ELMD vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between Electromed, Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab